Funding · Grant · 15 September 2026
Athernal Bio wins £700k Innovate UK grant
Athernal Bio has been awarded £700k in grant funding from Innovate UK. It builds immunotherapies that target pre-cancerous blood cells to intercept high-risk acute myeloid leukaemia. The money will go on preclinical validation studies and UK research collaborations.
Press report
CompanyAthernal Bio
StageGrant
SectorHealthTech
Based inElsewhere in the UK
InvestorsInnovate UK, Delin Ventures
SourcePress · confidence highView source ↗
Your note on Athernal Bio
Sign in to keep private notes on this company.
Is this your company?
Hide the valuation estimate straight away, add your investors, or tell us something's wrong. We check every change.